Saltar al contenido
República del Perú · Observatorio de la producción científica universitaria
OApol.org Observatorio de Inteligencia Científica Universitaria del Perú
OApol.org
Inicio Universidades Publicaciones Investigadores
Repositorios
Tesis y trabajos académicosRevistas
Indicadores
Ranking trimestralRanking por carreraObjetivos de Desarrollo SostenibleReporte OCDERed neuronal 3D
Acerca
MetodologíaPrivacidad

Abdominal obesity prevalence in Latin America: a systematic review and meta-analysis comparing ATP III and IDF criteria

Vera-Ponce V.J.; Loayza-Castro J.A.; Zuzunaga-Montoya F.E.; Vásquez-Romero L.E.M.; Sanchez-Tamay N.M.; Bustamante-Rodríguez J.C.; Ballena-Caicedo J.; Gutierrez De Carrillo C.I. · Frontiers in Endocrinology (2025) · DOI: 10.3389/fendo.2025.1562060

Resumen

Background: Abdominal obesity (AO) represents a significant cardiovascular risk factor with distinctive characteristics in Latin American populations. Its prevalence has increased substantially in recent decades, although estimates vary according to the diagnostic criteria. Objective: To determine the prevalence of AO in Latin American populations through a systematic review with meta-analysis, comparing ATP III and IDF criteria. Methods: A systematic search was conducted across SCOPUS, Web of Science, PubMed, and EMBASE databases. Observational studies evaluating AO prevalence in Latin American populations using either ATP III (≥102/88 cm) or IDF (≥90/80 cm) criteria were included. Meta-regressions were performed to assess the influence of publication year and sample size. Results: Sixty-one studies were included (n=281,694 participants). The pooled prevalence according to ATP III criteria was 40% (95% CI: 34-46%) and 62% (95% CI: 56-68%) according to IDF criteria. Sex-stratified analysis revealed significantly higher prevalences in women (ATP III: 50% vs 27%; IDF: 74.3% vs 46.8%). Temporal meta-regression demonstrated an upward trend, particularly in studies utilizing IDF criteria, while sample size showed no significant influence on prevalence estimates. Substantial geographic variations were observed, with Mexico and Venezuela exhibiting the highest prevalences. Heterogeneity was considerably high (I²>99%) across all analyses. Conclusions: AO prevalence in Latin America is high and demonstrates significant sexual dimorphism. These findings challenge the validity of current cut-off points and suggest the need to develop Latin American-specific criteria based on clinically relevant outcomes. Copyright

Instituciones: Universidad Continental; Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas